Related Experiment Video
Updated: Jun 5, 2026

Infection of In Vivo and In Vitro Pines with the Pinewood Nematode Bursaphelenchus xylophilus and Isolation of Induced Volatiles
Published on: September 27, 2024
Ring B aromatic norpimarane glucoside from a Xylaria sp
Masahiko Isaka1, Arunrat Yangchum, Patchanee Auncharoen
1National Center for Genetic Engineering and Biotechnology (BIOTEC), 113 Thailand Science Park, Phaholyothin Road, Klong Luang, Pathumthani 12120, Thailand. isaka@biotec.or.th
A new compound, xylopimarane, was isolated from Xylaria fungus. This natural product shows significant potential as an anticancer agent, demonstrating cytotoxicity against multiple cancer cell lines.
Area of Science:
- Natural Product Chemistry
- Pharmacology
- Mycology
Background:
- Fungi are a rich source of diverse bioactive natural products.
- The genus Xylaria is known to produce various secondary metabolites with potential biological activities.
Purpose of the Study:
- To isolate and characterize novel compounds from the fungus Xylaria sp. BCC 4297.
- To evaluate the cytotoxic activity of isolated compounds against human cancer cell lines.
Main Methods:
- Chemical isolation and structure elucidation of compounds from fungal extracts.
- In vitro cytotoxicity assays using cancer cell lines (KB, MCF-7, NCI-H187).
Main Results:
- A novel 20-norpimarane glucoside, xylopimarane (1), was identified.
- Known compounds sphaeropsidin C (2) and clonostachydiol (3) were also isolated.
- Xylopimarane (1) exhibited potent cytotoxicity against KB (IC50 = 1.0 μM), MCF-7 (IC50 = 13 μM), and NCI-H187 (IC50 = 65 μM) cancer cell lines.
Conclusions:
- Xylopimarane is a novel cytotoxic compound isolated from Xylaria sp.
- The findings suggest xylopimarane as a potential lead compound for anticancer drug development.
Related Concept Videos
Olefin Metathesis Polymerization: Ring-Opening Metathesis Polymerization (ROMP)
NMR Spectroscopy of Aromatic Compounds

